Market Snapshot
Dow Futures
32,758
S&P Futures
4,127.25
Nasdaq Futures
13,031
Alimera Sciences, Inc. (ALIM) stock declined over -0.02% intraday to trade at $7.18 a share on NASDAQ. The stock opened with a gain of 6.69% at $7.07 and touched an intraday high of $7.536, rising 2.57% against the last close of $7. The stock went to a low of $7.06 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-08 | $7.07 | $7.536 | $7.06 | $7.181 | 17,803 |
2022-08-05 | $6.73 | $7 | $6.3 | $7 | 29,900 |
2022-08-04 | $7.65 | $7.68 | $6.52 | $6.751 | 25,600 |
2022-08-03 | $6.33 | $7.92 | $6.33 | $7.7 | 69,300 |
2022-08-02 | $5.47 | $6.3 | $5.47 | $6.3 | 91,000 |
2022-08-01 | $5.61 | $5.835 | $5.4 | $5.46 | 9,800 |
2022-07-29 | $5.4 | $5.84 | $5.4 | $5.71 | 9,400 |
2022-07-28 | $5.57 | $5.78 | $5.32 | $5.33 | 5,400 |
2022-07-27 | $5.2 | $6.04 | $5.2 | $5.49 | 25,500 |
2022-07-26 | $5.35 | $5.35 | $5.13 | $5.15 | 12,000 |
Employees-
Beta1.41
Sales or Revenue52.61 Million
5Y Sales Change11.4%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryPharmaceuticals
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
Alimera Sciences, Inc. (NASDAQ: ALIM) stock price is $7.18 as of the last check on Monday, August 8. During the trading session, ALIM stock reached the peak price of $7.536 while $7.06 was the lowest point it dropped to.
The NASDAQ listed ALIM is part of Pharmaceuticals industry that operates in the broader Health Care sector. Alimera Sciences, Inc. , a pharmaceutical company, engages in the development and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally.
Mr. Charles Daniel Myers
Non-Exec. Chairman & Consultant
Mr. Richard S. Eiswirth Jr.
Pres, CEO & Director
Mr. David R. Holland
Co-Founder, Chief Marketing Officer and Sr. VP of Corp. Communications & Managed Markets
Dr. Philip Ashman Ph.D.
COO & Sr. VP of Commercial Operations - Europe
ALIM stock traded closed the last session at $7.181, which is -$0.0015000000000000568 or -0.020887001322844212% lower than its previous close of $7. ALIM's current trading price is 82.27% lower than its 52-week high of $9.79 where as its distance from 52-week low of 3.94% is -26.64%.
Number of ALIM employees currently stands at -. ALIM operates from 6310 Town Square, Suite 400, Alpharetta, GA 30005, United States.
Official Webiste of $ALIM is: https://alimerasciences.com
ALIM could be contacted at ALIM operates from 6310 Town Square, Suite 400, Alpharetta, GA 30005, United States, or at phone #678 990 5740 and can also be accessed through its website.
ALIM stock volume for the day was 5,935 shares while in the previous session number of ALIM shares traded was 17,803 . The average number of ALIM shares traded daily for last 3 months was 21.18 Thousands.
The percentage change in ALIM stock occurred in the recent session was -0.020887001322844212% while the dollar amount for the price change in ALIM stock was -$0.0015000000000000568.
In the recent session, the day high for ALIM stock was $7.536 while the low for ALIM stock touched on the day was $7.06.
The market value of ALIM currently stands at 48.55 Million with its latest stock price at $7.18 and 6.99 Million of its shares outstanding.